Sander Slootweg
InvestorManaging Partner at Forbion
Netherlands
Writes $100K – $5M checks · typically $1.5M
About
Sander Slootweg is Managing Partner at Forbion, which he co-founded in 2006 after co-founding ABN AMRO Capital/Life Sciences in 2000. His earlier roles at ABN AMRO Bank included buy-out and growth equity investing, equity capital markets syndications, and financial institutions relationship management for Latin America. He holds degrees in Business and Financial Economics from the Free University of Amsterdam and in Business Administration from Nyenrode University, and focuses on life sciences investing.
Invests in
Biotech
Experience
- ForbionCo-owner and Managing Partnercurrent2006 — presentNaarden, North Holland, Netherlands
- ABN AMRO BankDirector1993 — 2006
Education
- Vrije Universiteit Amsterdam (VU Amsterdam)MSc, Economics/Finance1989 — 1992
- Nyenrode Business UniversityBBA, Business1986 — 1989
- Gemeentelijk Gymnasium Hilversum AlumniGymnasium1980 — 1986
Skills & more
+1 more
Venture CapitalFrom Sander's professional profile.
Investments
Board seats
AzafarosForbion European Acquisition CorpNewAmsterdam PharmaNorthSea TherapeuticsReplimuneuniQure
Per the firm's website.
Colleagues at Forbion
Frequently asked questions
- Where does Sander Slootweg work?
- Sander Slootweg is Managing Partner at Forbion.
- What does Sander Slootweg invest in?
- Sander Slootweg invests in Biotech.
- What check size does Sander Slootweg write?
- Sander Slootweg typically writes checks of $100K – $5M.
Same school
Also attended Vrije Universiteit Amsterdam (VU Amsterdam)145
+ 139 more
Also attended Nyenrode Business University47
+ 41 more
Also attended Gemeentelijk Gymnasium Hilversum Alumni1
Shared employers
Also worked at Forbion23
+ 17 more
Also worked at ABN AMRO Bank142
+ 136 more





























